Vector BioMed Enhances LENTIVERSE™ and Launches New Brand for Global Patient Access Vector BioMed has unveiled its expanded LENTIVERSE™ platform and new brand identity, aimed at increasing accessibility to gene therapies worldwide. Discover its innovations.

Vector BioMed Enhances LENTIVERSE™ and Launches New Brand for Global Patient Access #United_States #Gaithersburg #Cell_Therapy #Vector_BioMed #LENTIVERSE

Vector BioMed and Muni Seva Ashram Team Up to Enhance Cancer Care Access in Rural India Vector BioMed partners with Muni Seva Ashram to provide CAR-T therapy in rural India, offering hope for affordable cancer treatments.

Vector BioMed and Muni Seva Ashram Team Up to Enhance Cancer Care Access in Rural India #India #Vector_BioMed #Gujarat #Muni_Seva_Ashram #Kailash_Cancer_Hospital

Vector BioMed CEO to Showcase Melting Barriers in Gene Therapy at Major 2025 Industry Events Vector BioMed is poised to present its groundbreaking LENTIVERSE platform, advancing gene therapy access at ISCT and ASGCT 2025. Join the revolution.

Vector BioMed CEO to Showcase Melting Barriers in Gene Therapy at Major 2025 Industry Events #USA #New_Orleans #Vector_BioMed #LENTIVERSE #Dr._Boro_Dropulic

Boro Dropulic to Offer Key Insights on Cell Therapies at Advanced Therapies Week 2025 Join Boro Dropulic at Advanced Therapies Week 2025 for discussions on cell and gene therapies, accessibility, and commercialization strategies.

Boro Dropulic to Offer Key Insights on Cell Therapies at Advanced Therapies Week 2025 #United_States #Dallas #Caring_Cross #Vector_BioMed #Boro_Dropulic